BLT 0.00% 2.6¢ benitec biopharma limited

This is where have IP issues. UniQure did license ddRNAi from us...

  1. 4,015 Posts.
    lightbulb Created with Sketch. 127
    This is where have IP issues. UniQure did license ddRNAi from us but the way they are applying it may end up being covered by CSHL's IP. Not much point in worrying about it as Graham patent expires in six months.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.